Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation
NCT00065286 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2005-06-24
Summary
Akathisia is a movement disorder that is often a side effect of certain psychiatric drugs. People with akathisia are unable to sit or keep still, complain of restlessness, fidget, rock from foot to foot, and pace. Akathisia is sometimes called "restless legs syndrome." The drugs that can cause akathisia are most often used to treat patients with schizophrenia or mental retardation (MR). This study will evaluate akathisia in both schizophrenic and MR patients who either have long-term akathisia or who are starting treatment with psychiatric drugs.
Conditions
- Akathisia
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
Karl M Newell, Ph. D. · Department of Kinesiology
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1996-12-31
- Completion
- 1999-11-30
Countries
- United States
Study Locations
More Related Trials
-
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
NCT01036568 ·Status: COMPLETED
-
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
NCT03062033 ·Status: UNKNOWN
-
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
NCT00686699 ·Status: TERMINATED ·Phase: PHASE2
-
Aerobic Exercise for Cognition in Schizophrenia
NCT02621983 ·Status: COMPLETED ·Phase: NA
-
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia
NCT03280810 ·Status: COMPLETED ·Phase: NA
-
Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment
NCT00161057 ·Status: COMPLETED
-
Biomarker Study of Acamprosate in Schizophrenia
NCT00688324 ·Status: COMPLETED ·Phase: PHASE4
-
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia
NCT04655235 ·Status: RECRUITING
-
Factors Association With Poor Physical Function in Older Adults With Schizophrenia
NCT01092598 ·Status: COMPLETED
-
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.
NCT01897064 ·Status: COMPLETED ·Phase: NA
-
Treatment of Psychosis and Agitation in Alzheimer's Disease
NCT02129348 ·Status: COMPLETED ·Phase: PHASE2
-
Internal Monitoring of Eye Movement in Schizophrenia
NCT01011101 ·Status: TERMINATED
-
The Effect of Progressive Muscle Relaxation on Psychological Symptoms and Mental Well-Being in Patients With Schizophrenia
NCT05324865 ·Status: UNKNOWN ·Phase: NA
-
Nicotinic Modulation of the Default Network
NCT01223404 ·Status: COMPLETED ·Phase: NA
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
NCT02205437 ·Status: UNKNOWN
-
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
NCT00942981 ·Status: COMPLETED
-
Sustained Attention Abilities in Schizophrenia
NCT02388607 ·Status: UNKNOWN
-
Plantar Sensation, Balance, Risk of Falling and Gait in Patients With Schizophrenia
NCT03476408 ·Status: COMPLETED ·Phase: NA
-
Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients
NCT04553835 ·Status: UNKNOWN ·Phase: NA
-
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
NCT01688037 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Cognition Via Exercise in Schizophrenia
NCT03270098 ·Status: COMPLETED ·Phase: NA
-
The Effect of Ketamine on Attentiveness
NCT01165294 ·Status: COMPLETED ·Phase: PHASE1
-
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism
NCT02675530 ·Status: COMPLETED ·Phase: PHASE1